Ya-Huei Kuo Selected Research

Toll-Like Receptor 9

1/2014

Push and release: TLR9 activation plus STAT3 blockade for systemic antitumor immunity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ya-Huei Kuo Research Topics

Disease

17	Leukemia 02/2024 - 04/2005
16	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 01/2006
9	Neoplasms (Cancer) 02/2024 - 05/2002
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2024 - 05/2016
2	Myeloid Leukemia (Leukemia, Myelocytic) 05/2016 - 04/2009
2	Neuroblastoma 06/2003 - 10/2002
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2023
1	Disease Progression 11/2023
1	Heart Diseases (Heart Disease) 03/2022
1	Colonic Neoplasms (Colon Cancer) 10/2020
1	Necrobiotic Disorders (Necrobiosis) 01/2020
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2016
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 07/2012

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 11/2023 - 06/2003
5	Tyrosine Kinase InhibitorsIBA 02/2024 - 10/2014
4	Peptides (Polypeptides)IBA 01/2020 - 05/2002
3	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2021
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 03/2016 - 01/2014
3	Core Binding Factors (Core-Binding Factor)IBA 04/2009 - 04/2005
3	Oncogene Proteins (Oncogene Protein)IBA 02/2008 - 01/2006
3	pro-insulin-like growth factor IIBA 06/2003 - 05/2002
2	Biomarkers (Surrogate Marker)IBA 03/2024 - 11/2023
2	Arginine (L-Arginine)FDA Link 02/2024 - 01/2019
2	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2022 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2019 - 09/2013
2	Sirtuin 1IBA 01/2018 - 10/2014
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 02/2024
1	Interferon Type IIBA 02/2024
1	ProteomeIBA 11/2023
1	CalcineurinIBA 03/2022
1	N-propionylprocainamideIBA 03/2022
1	Atrial Natriuretic Factor (ANF)IBA 03/2022
1	Messenger RNA (mRNA)IBA 03/2022
1	SAM Domain and HD Domain-Containing Protein 1IBA 01/2022
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2022
1	HydrolasesIBA 01/2022
1	triphosphoric acid (triphosphate)IBA 01/2022
1	nelarabine (506U78)FDA Link 01/2022
1	Guanosine Triphosphate (GTP)IBA 10/2020
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 10/2020
1	Ribosomal RNAIBA 10/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	PNC-27IBA 01/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2019
1	Protein Isoforms (Isoforms)IBA 05/2016
1	Transcription Factors (Transcription Factor)IBA 03/2016
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2014
1	OligonucleotidesIBA 01/2014
1	Small Interfering RNA (siRNA)IBA 01/2014
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2014
1	Therapeutic UsesIBA 01/2014
1	Toll-Like Receptor 9IBA 01/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2013
1	src-Family KinasesIBA 09/2013
1	Dasatinib (BMS 354825)FDA Link 09/2013
1	Thrombopoietin (c-mpl Ligand)IBA 07/2012
1	CytokinesIBA 07/2012
1	LigandsIBA 07/2012
1	4,5,6,7- tetrahydroisoxazolo(4,5- c)pyridin- 3- ol (THPO)IBA 07/2012
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 04/2009
1	Core Binding Factor beta SubunitIBA 12/2006
1	CBFbeta-MYH11 fusion proteinIBA 01/2006
1	Insulin-Like Growth Factor I (IGF-1)IBA 10/2002

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 10/2021 - 09/2013
3	Therapeutics 02/2024 - 01/2018
1	Injections 01/2014
1	Transplantation 04/2009